Promega Maxwell CSC system

Monday, 01 July, 2013 | Supplied by: Promega Pty Ltd


Promega has launched the Maxwell CSC instrument and integrated reagent kits for blood DNA and DNA FFPE. The solutions have been developed in compliance with the FDA’s Quality System Regulation and are intended as in vitro diagnostic (IVD) medical devices. Complying with these stringent requirements ensures consistent performance between instruments and runs.

The technology extracts nucleic acid using novel paramagnetic particles, allowing optimal capture, wash and elution of the target material. Because there are no tubes or pipette tips involved, there are no clogs, drips, splashing or aerosols, reducing any contamination risk. Depending on which specific CSC kits are used (for blood or FFPE tissues), the instrument can purify DNA from up to 16 samples in under 45 min of processing time, providing high-quality nucleic acids appropriate for downstream analysis in amplification-based assays.

The system’s Windows 7-based touch-screen interface provides laboratories with the ability to easily track samples, instrument self-check reports, kit lot number and expiration dates, and operator usage, and to document parameters and protocols.

Online: www.promega.com
Phone: 03 9818 1466
Related Products

Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium

The products provide researchers and manufacturers with high-performance, scalable and...

Grace Bio-Labs protein microarray tools

Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...

Siemens Healthineers 3gAllergy assay

Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd